1
|
Siris ES, Adler R, Bilezikian J, Bolognese
M, Dawson-Hughes B, Favus MJ, Harris ST, Jan de Beur SM, Khosla S,
Lane NE, et al: The clinical diagnosis of osteoporosis: A position
statement from the National Bone Health Alliance Working Group.
Osteoporos Int. 25:1439–1443. 2014.PubMed/NCBI View Article : Google Scholar
|
2
|
Khosla S and Hofbauer LC: Osteoporosis
treatment: Recent developments and ongoing challenges. Lancet
Diabetes Endocrinol. 5:898–907. 2017.PubMed/NCBI View Article : Google Scholar
|
3
|
Lötters FJB, van den Bergh JP, de Vries F
and Rutten-van Mölken MP: Current and future incidence and costs of
osteoporosis-related fractures in the Netherlands: Combining claims
data with BMD measurements. Calcif Tissue Int. 98:235–243.
2016.PubMed/NCBI View Article : Google Scholar
|
4
|
Curtis EM, Moon RJ, Dennison EM, Harvey NC
and Cooper C: Recent advances in the pathogenesis and treatment of
osteoporosis. Clin Med (Lond). 15 (Suppl 6):S92–S96.
2015.PubMed/NCBI View Article : Google Scholar
|
5
|
Raisz LG: Pathogenesis of osteoporosis:
Concepts, conflicts, and prospects. J Clin Invest. 115:3318–3325.
2005.PubMed/NCBI View
Article : Google Scholar
|
6
|
Reyes J, Chen JY, Stewart-Ornstein J,
Karhohs KW, Mock CS and Lahav G: Fluctuations in p53 signaling
allow escape from cell-cycle arrest. Mol Cell. 2018. 71:581–591.
e5. 2018.PubMed/NCBI View Article : Google Scholar
|
7
|
Willms A, Schittek H, Rahn S, Sosna J,
Mert U, Adam D and Trauzold A: Impact of p53 status on
TRAIL-mediated apoptotic and non-apoptotic signaling in cancer
cells. PLoS One. 14(e0214847)2019.PubMed/NCBI View Article : Google Scholar
|
8
|
Yeo CQX, Alexander I, Lin Z, Lim S, Aning
OA, Kumar R, Sangthongpitag K, Pendharkar V, Ho VHB and Cheok CF:
p53 maintains genomic stability by preventing interference between
transcription and replication. Cell Rep. 15:132–146.
2016.PubMed/NCBI View Article : Google Scholar
|
9
|
Hirasawa H, Tanaka S, Sakai A, Tsutsui M,
Shimokawa H, Miyata H, Moriwaki S, Niida S, Ito M and Nakamura T:
ApoE gene deficiency enhances the reduction of bone formation
induced by a high-fat diet through the stimulation of p53-mediated
apoptosis in osteoblastic cells. J Bone Miner Res. 22:1020–1030.
2007.PubMed/NCBI View Article : Google Scholar
|
10
|
Weinstein RS and Manolagas SC: Apoptosis
and osteoporosis. Am J Med. 108:153–164. 2000.PubMed/NCBI View Article : Google Scholar
|
11
|
Zhen YF, Wang GD, Zhu LQ, Tan SP, Zhang
FY, Zhou XZ and Wang XD: P53 dependent mitochondrial permeability
transition pore opening is required for dexamethasone-induced death
of osteoblasts. J Cell Physiol. 229:1475–1483. 2014.PubMed/NCBI View Article : Google Scholar
|
12
|
Hao L, Fu J, Tian Y and Wu J: Systematic
analysis of lncRNAs, miRNAs and mRNAs for the identification of
biomarkers for osteoporosis in the mandible of ovariectomized mice.
Int J Mol Med. 40:689–702. 2017.PubMed/NCBI View Article : Google Scholar
|
13
|
Cui L, Nai M, Zhang K, Li L and Li R:
lncRNA WT1-AS inhibits the aggressiveness of cervical cancer cell
via regulating p53 expression via sponging miR-330-5p. Cancer Manag
Res. 11:651–667. 2019.PubMed/NCBI View Article : Google Scholar
|
14
|
Coulson KA, Reed G, Gilliam BE, Kremer JM
and Pepmueller PH: Factors influencing fracture risk, T score, and
management of osteoporosis in patients with rheumatoid arthritis in
the Consortium of Rheumatology Researchers of North America
(CORRONA) registry. J Clin Rheumatol. 15:155–160. 2009.PubMed/NCBI View Article : Google Scholar
|
15
|
Al-Azzawi F: Prevention of postmenopausal
osteoporosis and associated fractures: Clinical evaluation of the
choice between estrogen and bisphosphonates. Gynecol Endocrinol.
24:601–609. 2008.PubMed/NCBI View Article : Google Scholar
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
17
|
Du T, Zhang B, Zhang S, Jiang X, Zheng P,
Li J, Yan M, Zhu Z and Liu B: Decreased expression of long
non-coding RNA WT1-AS promotes cell proliferation and invasion in
gastric cancer. Biochim Biophys Acta. 1862:12–19. 2016.PubMed/NCBI View Article : Google Scholar
|
18
|
Dai SG, Guo LL, Xia X and Pan Y: Long
non-coding RNA WT1-AS inhibits cell aggressiveness via
miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical
cancer. Eur Rev Med Pharmacol Sci. 23:486–495. 2019.PubMed/NCBI View Article : Google Scholar
|
19
|
Komori T: Cell death in chondrocytes,
osteoblasts, and osteocytes. Int J Mol Sci. 17(2045)2016.PubMed/NCBI View Article : Google Scholar
|
20
|
Lorentzon M and Cummings SR: Osteoporosis:
The evolution of a diagnosis. J Intern Med. 277:650–661.
2015.PubMed/NCBI View Article : Google Scholar
|
21
|
Thomson DW and Dinger ME: Endogenous
microRNA sponges: Evidence and controversy. Nat Rev Genet.
17:272–283. 2016.PubMed/NCBI View Article : Google Scholar
|
22
|
Yu Y, Newman H, Shen L, Sharma D, Hu G,
Mirando AJ, Zhang H, Knudsen E, Zhang GF, Hilton MJ, et al:
Glutamine metabolism regulates proliferation and lineage allocation
in skeletal stem cells. Cell Metab. 29:966–978. e4. 2019.PubMed/NCBI View Article : Google Scholar
|
23
|
Hayashi M, Nakashima T, Yoshimura N,
Okamoto K, Tanaka S and Takayanagi H: Autoregulation of osteocyte
Sema3A orchestrates estrogen action and counteracts bone aging.
Cell Metab. 29:627–637.e5. 2019.PubMed/NCBI View Article : Google Scholar
|
24
|
Fan Y, Hanai JI, Le PT, Bi R, Maridas D,
DeMambro V, Figueroa CA, Kir S, Zhou X, Mannstadt M, et al:
Parathyroid hormone directs bone marrow mesenchymal cell fate. Cell
Metab. 25:661–672. 2017.PubMed/NCBI View Article : Google Scholar
|
25
|
Stegen S, van Gastel N, Eelen G,
Ghesquière B, D'Anna F, Thienpont B, Goveia J, Torrekens S, Van
Looveren R, Luyten FP, et al: HIF-1α promotes glutamine-mediated
redox homeostasis and glycogen-dependent bioenergetics to support
postimplantation bone cell survival. Cell Metab. 23:265–279.
2016.PubMed/NCBI View Article : Google Scholar
|
26
|
Liu S, Liu D, Chen C, Hamamura K,
Moshaverinia A, Yang R, Liu Y, Jin Y and Shi S: MSC transplantation
improves osteopenia via epigenetic regulation of notch signaling in
lupus. Cell Metab. 22:606–618. 2015.PubMed/NCBI View Article : Google Scholar
|
27
|
Mera P, Laue K, Ferron M, Confavreux C,
Wei J, Galán-Díez M, Lacampagne A, Mitchell SJ, Mattison JA, Chen
Y, et al: Osteocalcin signaling in myofibers is necessary and
sufficient for optimum adaptation to exercise. Cell Metab.
23:1078–1092. 2016.PubMed/NCBI View Article : Google Scholar
|